CAS 190006-01-0: 17-beta-(n-butylcarbamoyl)-5-oxo-3,5-secoandrostan-2-oic acid
CAS 190006-01-0: 17-beta-(n-butylcarbamoyl)-5-oxo-3,5-secoandrostan-2-oic acid
Description:17-beta-(n-butylcarbamoyl)-5-oxo-3,5-secoandrostan-2-oic acid, with the CAS number 190006-01-0, is a synthetic steroid derivative that exhibits characteristics typical of anabolic steroids. This compound features a modified steroid backbone, which includes a 5-oxo group and a seco structure, indicating a cleavage in the steroid framework. The presence of the n-butylcarbamoyl group suggests that it may have enhanced lipophilicity, potentially affecting its bioavailability and pharmacokinetics. As a derivative of androstane, it may interact with androgen receptors, influencing anabolic processes in muscle tissue. The compound's structure implies potential applications in therapeutic contexts, particularly in hormone replacement therapies or muscle-wasting conditions. However, its specific biological activity, efficacy, and safety profile would require thorough investigation through pharmacological studies. Additionally, as with many steroid derivatives, there may be regulatory considerations regarding its use in sports and medicine due to potential performance-enhancing effects.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.